Physician

Minal M Shah, M.D.

According to 2025 Medicare claims, Minal Shah, M.D. (NPI: 1265683171) practices hematology/oncology in the Lexington Park, MD market, with the plurality of this provider's patient population coming from St. Marys, MD. This provider's primary affiliated billing organization is MEDSTAR MEDICAL GROUP - SOUTHERN MARYLAND LLC (NPI: 1831592211; TIN: 462691028) and primary practice location at 20619-4018.

Shah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 969 traditional Medicare patients, billed 281,406 HCPCS/CPT codes, and received $5,162,708 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,179 prescription claims across 223 beneficiaries totaling $5,243,202 in drug costs, led by Lenalidomide (Lenalidomide). DME data shows 213 claims. Open Payments data shows 93 records totaling $2,363. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $2,065,973 to $5,162,708. Similarly, Part D prescription costs have risen steadily, from $446,966 to $5,243,202. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	763	124,411	$2,065,973
2016	883	180,722	$2,028,875
2017	938	197,809	$2,432,455
2018	991	209,530	$2,952,233
2019	1,072	196,520	$2,771,325
2020	937	245,016	$3,222,313
2021	974	305,946	$4,964,446
2022	1,113	314,947	$5,244,441
2023	1,031	352,785	$6,467,876
2024	969	281,406	$5,162,708

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	64	298	$446,966
2016	81	357	$677,186
2017	83	349	$890,023
2018	92	452	$1,249,229
2019	95	534	$2,164,190
2020	105	602	$2,681,573
2021	131	760	$2,628,826
2022	146	685	$2,882,758
2023	162	698	$3,039,447
2024	223	1,179	$5,243,202

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	14	$263
2016	N/R	14	$12,373
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	12	$2,211
2020	N/R	107	$61,445
2021	N/R	36	$2,147
2022	23	67	$2,518
2023	N/R	12	$2,831
2024	N/R	213	$104,694

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	613	1,164	$88
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	494	916	$13
80053	Blood test, comprehensive group of blood chemicals	311	991	$10
36415	Insertion of needle into vein for collection of blood sample	671	2,289	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	642	2,282	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	53	1,484	$721,446
Erleada	Apalutamide	39	1,170	$579,422
Revlimid	Lenalidomide	29	812	$513,991
Verzenio	Abemaciclib	34	961	$458,065
Imbruvica	Ibrutinib	22	788	$437,890

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4197	Parenteral nutrition solution; compounded amino acid and carbohydrates with electrolytes, trace elements and vitamins, including preparation, any strength, 74 to 100 grams of protein - premix	N	N/R	37	$77,602
B4185	Parenteral nutrition solution, not otherwise specified, 10 grams lipids	N	N/R	37	$16,140
B4224	Parenteral nutrition administration kit, per day	N	N/R	38	$7,132
B4220	Parenteral nutrition supply kit; premix, per day	N	N/R	37	$2,274
J8521	Capecitabine, oral, 500 mg	N	N/R	29	$888

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	93	$2,363	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Minal M. Shah, M.D.?

Tedicare shows public-source Medicare data for Minal M. Shah, M.D. (NPI 1265683171), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Minal M. Shah, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Minal M. Shah, M.D.?

Minal M. Shah, M.D. is linked to MEDSTAR MEDICAL GROUP - SOUTHERN MARYLAND LLC (billing NPI 1831592211) in the available physician profile data.

Does Minal M. Shah, M.D. have Open Payments data?

Minal M. Shah, M.D. has 93 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.